Eli Lilly cuts Zepbound price to widen access for obesity drug
Eli Lilly said on Monday it has lowered the price of single-dose vials of its popular obesity drug Zepbound to make the treatment more affordable for U.S. patients, as demand for
December 01, 2025
Growing up with ‘Toy Story’: Andrew Stanton on 30+ years with Woody and Buzz
Bison ranch fights to preserve a nearly extinct American icon
European Parliament backs EU-wide consent-based definition of rape
Panama's Copa Airlines to buy 60 Boeing 737 Max jets
FedEx, UPS vow to return tariff refunds to customers
Argentina’s Milei walks fine line on Falklands amid US–UK tensions
The mighty NL Central is the majors' only division with 5 winning teams
Rockets' Kevin Durant makes progress with injury but a return for Game 5 vs. Lakers seems unlikely